Advertisement
Screener

CYPHERPUNK TECHNOLOGIES INC. (CYPH) Increase (Decrease) in Deferred Charges

2.8 / 5 stars · 68/120 Roast Me

CYPHERPUNK TECHNOLOGIES INC. Increase (Decrease) in Deferred Charges

CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Increase (Decrease) in Deferred Charges of -$209.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-24.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2023-03-24

  • CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred charges for the quarter ending 2021-12-31 was $0.00.
  • CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred charges for the quarter ending 2021-09-30 was $0.00.
  • CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred charges for fiscal 2021 was -$209.00K.
Period endIncrease (Decrease) in Deferred Charges 3 monthIncrease (Decrease) in Deferred Charges 6 monthIncrease (Decrease) in Deferred Charges 9 monthIncrease (Decrease) in Deferred Charges 12 month
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24
$0.00
derived: sum of 2 quarters · filed 2023-03-24
-$209.00K
10-K · filed 2023-03-24
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$209.00K
10-Q · filed 2022-11-14
2021-06-30-$209.00K
10-Q · filed 2022-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06